|
July 24, 2006
Thousands of U.S. residents are having their prescription drug orders from Canada seized as a result of a policy change last November that some lawmakers and other critics allege is "intended to protect U.S. drug makers' sales at high domestic prices," the Wall Street Journal reports.
In the past, U.S. Customs and Border Protection and the FDA "had tended to turn a blind eye" toward individuals' drug purchases from Canada, but, as of Nov. 17, 2005, Customs has been regularly intercepting packages from Canadian pharmacies, the Journal reports. The policy change has resulted in the confiscation of 37,154 prescription drug orders. FDA said it began seizing packages because a large portion of drugs sent from Canada are counterfeit and might be unsafe for consumers, although some U.S. lawmakers from both parties have "cast doubt on the safety argument," according to the Journal (Carreyrou, Wall Street Journal, 7/24).
The Senate this month voted 68-32 to approve an amendment that would prohibit seizures by U.S. Customs and Border Protection of prescription drugs purchased from Canadian pharmacies by U.S. residents (iHealthBeat, 7/12).
Some critics suspect that the seizures are part of a campaign to encourage seniors to enroll in the new Medicare prescription drug benefit. Customs denies any connection between the new seizure policy and the Medicare drug plan. Customs spokesperson Lynn Hollinger said, "We're an independent government agency, and we are charged with enforcing the law."
Ken Johnson, senior vice president of the Pharmaceutical Research and Manufacturers of America, said, "Consumers may be risking their health by purchasing imported prescription drugs from purported Canadian Internet pharmacies - which have been known to sell fake and potentially unsafe medicines to unknowing American consumers - and may be run by shady dealers in countries such as India, China and North Korea" (Wall Street Journal, 7/24).
iHealthBeat is published daily for California HealthCare Foundation by
The Advisory Board Company. © 2004 The Advisory Board Company. All Rights Reserved.
|
